Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
AnemiaChronic Renal Insufficiency
Interventions
DRUG

HX575 solution for s.c. administration

Containing different strengths of epoetin alfa (1 to 10 KIU), s.c. injection, 1x per week (qw) or 1x every two weeks (q2w), injection into abdomen or upper thigh

Trial Locations (19)

1431

"MHATSveti Ivan Rilski", Sofia

4400

MHAT Pazardzhik, Pazardzhik

5300

"MHAT Dr. Tota Venkova", Gabrovo

9000

"MHAT Sveta Anna", Varna

12045

KfH Nierenzentrum, Berlin

23538

Gemeinschaftspraxis Dr. Spitthöver, Dr. Knee, Dr. Gröschel, Essen

28222

Hospital Universitario Puerta de Hierro, Majadahonda

31008

Hospital de Navarra, Pamplona

33077

Polyclinique de Bordeaux-Nord, Bordeaux

55232

Gesundheitszentrum Alzey Internistische Gemeinschaftspraxis, Slzrx

64732

KfH Nierenzentrum, Bad König

68309

Universitätsklinikum Schleswig-Holstein, Lübeck

69469

Nierenzentrum Weinheim Kreiskrankenhaus Weinheim, Weinheim

87042

Centre Hospitalier Universitaire Limoges, Hôpital Dupuytren, Limoges

300736

Spitalul Clinic Judetean Timisoara, Timișoara

330084

Spitalul Judetean de Urgenta Deva, Deva

410169

"Spitalul Clinic Municipal Dr. Gavril Curteanu", Oradea

010731

Spitalul Clinic de Nefrologie Dr. Carol Davila, Bucharest

050098

Spitalul Universitar de Urgenta Bucuresti, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sandoz

INDUSTRY